|
B3GNT5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.53370000535824E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.15940000050752E-07 |
| Normal-vs-Stage2 |
3.551500E-04 |
| Normal-vs-Stage3 |
1.7354000000358E-06 |
| Normal-vs-Stage4 |
1.46469999995347E-06 |
| Stage1-vs-Stage2 |
6.144200E-01 |
| Stage1-vs-Stage3 |
2.066600E-01 |
| Stage1-vs-Stage4 |
1.735830E-01 |
| Stage2-vs-Stage3 |
6.707800E-01 |
| Stage2-vs-Stage4 |
6.831600E-01 |
| Stage3-vs-Stage4 |
9.401000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.99430000291656E-08 |
| Normal-vs-AfricanAmerican |
7.042200E-02 |
| Normal-vs-Asian |
3.013000E-01 |
| Caucasian-vs-AfricanAmerican |
1.186000E-04 |
| Caucasian-vs-Asian |
6.225600E-01 |
| AfricanAmerican-vs-Asian |
4.030000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.10090000005059E-07 |
| Normal-vs-Female |
1.10789999951955E-07 |
| Male-vs-Female |
2.249600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.537600E-03 |
| Normal-vs-Age(41-60Yrs) |
2.05880000048175E-07 |
| Normal-vs-Age(61-80Yrs) |
9.15610000040701E-08 |
| Normal-vs-Age(81-100Yrs) |
1.979080E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.430200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.812600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.261200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.415600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.830800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.495000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.570080E-02 |
| Normal-vs-Grade 2 |
1.55489999986713E-07 |
| Normal-vs-Grade 3 |
9.71210001310396E-09 |
| Normal-vs-Grade 4 |
2.796100E-04 |
| Grade 1-vs-Grade 2 |
2.616200E-01 |
| Grade 1-vs-Grade 3 |
2.017600E-01 |
| Grade 1-vs-Grade 4 |
3.671400E-01 |
| Grade 2-vs-Grade 3 |
4.452600E-01 |
| Grade 2-vs-Grade 4 |
6.490000E-01 |
| Grade 3-vs-Grade 4 |
4.019600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.14490000707934E-09 |
| Normal-vs-ccB subtype |
9.58360000025138E-07 |
| ccA subtype-vs-ccB subtype |
5.910000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.68599999966968E-07 |
| Normal-vs-N1 |
1.473660E-02 |
| N0-vs-N1 |
7.367200E-01 |
|
|
